NCT07198139Phase 1, phase 2Completed

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus

Study sponsor: Cocrystal Pharma, Inc. · COCP

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-09-14Actual
Enrollment · participants32Actual
Source updated2026-10-22Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.